These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities. Butterworth RF J Steroid Biochem Mol Biol; 2016 Jun; 160():94-7. PubMed ID: 26589093 [TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of Hepatic Encephalopathy. Jaffe A; Lim JK; Jakab SS Clin Liver Dis; 2020 May; 24(2):175-188. PubMed ID: 32245525 [TBL] [Abstract][Full Text] [Related]
4. Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy. Jones EA Metab Brain Dis; 2002 Dec; 17(4):275-81. PubMed ID: 12602504 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited. Butterworth RF Metab Brain Dis; 2016 Dec; 31(6):1211-1215. PubMed ID: 26521983 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy. Leke R; Bak LK; Iversen P; Sørensen M; Keiding S; Vilstrup H; Ott P; Portela LV; Schousboe A; Waagepetersen HS J Neurochem; 2011 Jun; 117(5):824-32. PubMed ID: 21395584 [TBL] [Abstract][Full Text] [Related]